Berkshire Hathaway combines exceptionally resilient businesses, low-cost insurance float, and enormous reinvestment capacity to compound shareholder wealth, although elevated valuation and post-Buffett execution risks constrain near-term upside.
Marsh combines a durable global insurance brokerage moat, strong capital returns, and improving adjusted earnings at a historically attractive valuation, although insurance pricing weakness and persistent integration costs could limit upside.
Progressive combines superior auto-insurance underwriting, durable scale advantages, and high returns on equity at a reasonable valuation, although slowing premium growth and potential claims-cost normalization could pressure earnings.
ICICI Bank combines a durable Indian deposit franchise, strong credit quality, and profitable long-term lending growth, although its premium valuation and recent net interest margin compression constrain the margin of safety.
Prudential is an elite, hyper-cash-generative Asian financial compounder trading at an irrationally distressed valuation due to blanket China pessimism, offering investors a massive margin of safety supported by a relentless $1.5 billion share buyback program.
Aegon is aggressively shrinking its share count and shedding European assets to forge a highly profitable, US-centric life insurance and wealth management compounder, offering a deeply discounted entry point for investors willing to look past the frictional accounting noise of its transatlantic pivot.
Palomar is an elite, hyper-profitable specialty insurance compounder leveraging an asset-light reinsurance model to generate mid-20s ROE and explosive top-line growth, currently trading at a severely distressed multiple despite executing flawlessly, though investors must vigilantly monitor its unseasoned casualty reserve development.
Assured Guaranty is a highly profitable, dominant bond insurer trading at a massive discount to its intrinsic book value, though investors must navigate the volatility of its alternative asset investments and long-tail public finance exposures.
Genworth is a deeply discounted, capital-returning special situation trading well below the value of its mortgage insurance subsidiary, though investors must tolerate extreme psychological and actuarial risk tied to its toxic legacy long-term care liabilities.
Hagerty is a monopolistic, highly profitable tollbooth on the multi-billion-dollar collector car ecosystem with compounding structural growth, though investors must vigilantly monitor underwriting volatility as the firm transitions to retaining 100% of its insurance risk.
Lemonade's AI-driven platform is fundamentally reshaping personal lines insurance with hyper-growth scaling, improving loss ratios, and impending EBITDA profitability, though intense competition and macro catastrophe risks necessitate vigilant monitoring.
Radian boasts an impenetrable balance sheet and a highly profitable legacy mortgage monopoly that funds aggressive share buybacks, but investors must maintain a neutral stance until the costly integration friction and margin decay from its $1.67 billion foray into global specialty insurance definitively stabilize.